Back
Biogen Vs. Sage Therapeutics Industry Stock Comparison
Sell
38
BIIB
Biogen
Last Price:
234.63
Seasonality Move:
11.79%
Sell
42
SAGE
Sage Therapeutics
Last Price:
20.38
Seasonality Move:
5.22%
Sell
38
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
- The current Biogen [BIIB] share price is $234.67. The Score for BIIB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- BIIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy, Sell or Hold?
- The current Sage Therapeutics [SAGE] share price is $20.39. The Score for SAGE is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- SAGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIIB Stock Price Chart
SAGE Stock Price Chart
What is Sage Therapeutics's stock price today?
-
The Sage Therapeutics share price today is $20.39
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.77 | Sell |
| Relative Strength Index (14 RSI): | 48.08 | Sell |
| Chaikin Money Flow: | 566195 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (226.09 - 240.37) | Buy |
| Bollinger Bands (100): | (240.93 - 271.47) | Sell |
SAGE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 58.14 | Buy |
| Chaikin Money Flow: | 871024 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.13 - 20.11) | Buy |
| Bollinger Bands (100): | (15.09 - 31.59) | Sell |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 231.25 | Buy |
| 20-day SMA: | 232 | Buy |
| 50-day SMA: | 245.66 | Sell |
| 200-day SMA: | 271.83 | Sell |
| 8-day EMA: | 231.85 | Buy |
| 20-day EMA: | 233.72 | Buy |
| 50-day EMA: | 243 | Sell |
| 200-day EMA: | 262.03 | Sell |
SAGE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.51 | Buy |
| 20-day SMA: | 19.19 | Buy |
| 50-day SMA: | 19.35 | Buy |
| 200-day SMA: | 35.35 | Sell |
| 8-day EMA: | 19.57 | Buy |
| 20-day EMA: | 19.31 | Buy |
| 50-day EMA: | 20.3 | Buy |
| 200-day EMA: | 30.51 | Sell |
Biogen Earnings Growth & BIIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.11 per share, and an increase next year of $0.55 per share.
Sage Therapeutics Earnings Growth & SAGE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.79 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and an increase next year of $2.74 per share.
Biogen Technical Analysis
| Nov 17 | Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 17 | 20 | 21 | 22 | 24 | 27 | 28 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sage Therapeutics Technical Analysis
| Nov 17 | Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 17 | 20 | 21 | 22 | 24 | 27 | 28 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||